Johns Hopkins ABX Guide
Tenofovir DF
INDICATIONS
FDA
FDA
- Treatment of HIV-infection in adults and pediatric patients (≥2 years of age, weighing ≥10 kg) in combination with other antiretroviral drugs.
- Treatment of HBV in adults and pediatric patients ≥2 years of age, weighing ≥10 kg
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Treatment of hepatitis in HIV-HBV co-infected pts.
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: January 14, 2021
Citation
Bernice, Fidelia. "Tenofovir DF." Johns Hopkins ABX Guide, The Johns Hopkins University, 2021. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540541/11/Tenofovir_DF.
Bernice F. Tenofovir DF. Johns Hopkins ABX Guide. The Johns Hopkins University; 2021. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540541/11/Tenofovir_DF. Accessed December 1, 2024.
Bernice, F. (2021). Tenofovir DF. In Johns Hopkins ABX Guide. The Johns Hopkins University. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540541/11/Tenofovir_DF
Bernice F. Tenofovir DF [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2021. [cited 2024 December 01]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540541/11/Tenofovir_DF.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Tenofovir DF
ID - 540541
A1 - Bernice,Fidelia,Pharm.D., BCIDP
Y1 - 2021/01/14/
BT - Johns Hopkins ABX Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540541/11/Tenofovir_DF
PB - The Johns Hopkins University
DB - Pediatrics Central
DP - Unbound Medicine
ER -
